blAST is a Bio-Labeled Antimicrobial Susceptibility Test (AST) that uses award-winning click chemistry to analyze antimicrobial sensitivity directly from urine samples.
blAST is a direct urine phenotypic AST that provides single-shift results in ~6 hours.
blAST bypasses the need for a growth phase and eliminates standard culture timelines. The simplified laboratory workflow provides actionable, accurate, and reliable AST results from metabolically-active pathogens.
blAST provides phenotypic information:
blAST uses an organism's own protein metabolism to create a fluorescent signal from pathogens that are still viable after being treated with antimicrobial agents. This signal can be measured on a fluorescent plate reader and used to calculate MIC.
blAST provides personalized results at the time of infection, eliminating culture bias and treatment delays from standard culture and isolation methods.
Precisely identifies the most effective antimicrobial reducing trial and error.
Straight forward, non-invasive testing for patients and providers.
Starting the right antimicrobial early, lowers the risk of infection return.
No bias from monomicrobial growth or culture conditions.
Enables ongoing adjustment of treatments for optimal outcomes.
Delivers results in ~6 hours, expediting treatment initiation.
Minimizes unnecessary antimicrobial exposure and potential side effects.
Aids in the battle against resistance by promoting appropriate antimicrobials.
| CytoSPAR BLAST | Industry Standard | |
|---|---|---|
| Tests Direct from Urine Sample | ✓ | |
| Bypasses Growth Phase for Analysis | ✓ | |
| Determines MIC | ✓ | ✓ |
| Direct Result Delivery to Provider | ✓ | |
| Results in ~6 hours | ✓ | |
| Objective Results | ✓ | |
| Works on both Gram-positive and Gram-negative bacteria | ✓ | ✓ |